Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001628280-26-000967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-05 | PCRX | RIKER LAUREN | SVP, Fin | S - Sale | $24.24 | -1,416 | 59.1K | -2% | -$34.3K | |
| 2026-01-06 | 2026-01-02 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $24.46 | -159 | 60.5K | -0.3% | -$3,889 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | S | D | 1,416 | $24.24 | 59,064.24 | D | — | — | (F3) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. |
| 2 | Common | Common Stock | 2026-01-02 | F | D | 159 | $24.46 | 60,480.24 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. (F2) Includes 1,075.242 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025. |